🔎 Trials Near Me

Utama › Penyakit Crohn › Arizona

Kajian klinikal Penyakit Crohn di Arizona

17 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi di Arizona.

Bandar di Arizona

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • GI Alliance - Sun City ( Site 5118), Sun City
  • University of Arizona Clinical and Translational Sciences Research Center ( Site 5111), Tucson
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Elite Clinical Studies /ID# 280477, Phoenix
  • Gi Alliance - Arizona Digestive Health - Sun City /ID# 284084, Sun City
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • AZ Gastro Care, Chandler
  • Spectrum Research Institute LLC, Gilbert
  • GI Alliance- Sun City, Sun City
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • AZ Gastro Care, Chandler
  • Research Solutions of Arizona, Litchfield Park
  • Mayo Clinic, Scottsdale
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Onyx Clinical Research - Site Number:8400021, Peoria
  • One of a Kind Clinical Research Center AZ, LLC-Site Number: 8400061, Scottsdale
  • Scottsdale Clinical Trials-Site Number: 8400145, Scottsdale
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Phoenix Children's Hospital /ID# 255766, Phoenix
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05995353

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • GI Alliance Sun City, Sun City
Mengambil pesertaFasa 4
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Mayo Clinic Arizona, Scottsdale
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05230173

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Phoenix Children's Hospital, Phoenix
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06100289

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Phoenix Childrens Hospital, Phoenix
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 22 Jun 2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Phoenix Children's Hospital, Phoenix
Mengambil pesertaFasa 4
Umur 6 hingga 17 · Semua jantina · Dikemas kini 27 Mei 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Phoenix Childrens Hospital - Thomas Rd - PIN, Phoenix
Mengambil pesertaFasa 3
Umur 2 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Phoenix Childrens Hospital, Phoenix
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 5 Mei 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Scottsdale Gastroenterology Specialists, Scottsdale
  • GI Alliance -Gurnee, Sun City
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400024, Tucson
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Scottsdale
  • Mirador Therapeutics Selected Site, Sun City
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

  • Mayo Clinic Arizona, Scottsdale
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 10 Dis 2025 · NCT06721962

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.